Request for Covid-19 Impact Assessment of this Report

Medical Devices

United States Diabetic Retinopathy Market Report 2021

  • QYR705506
  • 103 Pages
  • August 2016
  • Medical Devices
Download Sample    Get Discount   
 
This report studies sales (consumption) of Diabetic Retinopathy in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering

Bayer

F. Hoffmann-La Roche

Novartis

Regeneron Pharmaceuticals

Alimera Sciences

Ampio Pharmaceuticals

Kowa Group

Ohr Pharmaceutical

Promedior

PSivida

Quark Pharmaceuticals

ThromboGenics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Corticosteroids drugs

Anti-VEGF drugs

Others

Split by applications, this report focuses on sales, market share and growth rate of Diabetic Retinopathy in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

1 Diabetic Retinopathy Overview

1.1 Product Overview and Scope of Diabetic Retinopathy

1.2 Classification of Diabetic Retinopathy

1.2.11 Corticosteroids drugs

1.2.12 Anti-VEGF drugs

1.2.13 Others

1.3 Applications of Diabetic Retinopathy

1.4 USA Market Size (Value and Volume) of Diabetic Retinopathy (2011-2021)

1.4.1 USA Diabetic Retinopathy Sales, Revenue and Price (2011-2021)

1.4.2 USA Diabetic Retinopathy Sales and Growth Rate (2011-2021)

1.4.3 USA Diabetic Retinopathy Revenue and Growth Rate (2011-2021)

2 USA Diabetic Retinopathy Competition by Manufacturers

2.1 USA Diabetic Retinopathy Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Diabetic Retinopathy Revenue and Share by Manufactures (2015-2016)

3 USA Diabetic Retinopathy (Volume and Value) by Type

3.1 USA Diabetic Retinopathy Sales and Market Share by Type (2011-2021)

3.2 USA Diabetic Retinopathy Revenue and Market Share by Type (2011 and 2021)

4 USA Diabetic Retinopathy (Volume) by Application

5 USA Diabetic Retinopathy Manufacturers Analysis

5.1 Bayer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Diabetic Retinopathy Product Type and Technology

5.1.2.1 Corticosteroids drugs

5.1.2.2 Anti-VEGF drugs

5.1.3 Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)

5.2 F. Hoffmann-La Roche

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharma & Healthcare Product Type and Technology

5.2.2.1 Corticosteroids drugs

5.2.2.2 Anti-VEGF drugs

5.2.3 Pharma & Healthcare Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)

5.3 Novartis

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Novartis Product Type and Technology

5.3.2.1 Corticosteroids drugs

5.3.2.2 Anti-VEGF drugs

5.3.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)

5.4 Regeneron Pharmaceuticals

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Promedior Product Type and Technology

5.4.2.1 Corticosteroids drugs

5.4.2.2 Anti-VEGF drugs

5.4.3 Regeneron Pharmaceuticals Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)

5.5 Alimera Sciences

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Alimera Sciences Product Type and Technology

5.5.2.1 Corticosteroids drugs

5.5.2.2 Anti-VEGF drugs

5.5.3 Alimera Sciences Sales, Revenue, Price of Alimera Sciences (2015 and 2016)

5.6 Ampio Pharmaceuticals

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Ampio Pharmaceuticals Product Type and Technology

5.6.2.1 Corticosteroids drugs

5.6.2.2 Anti-VEGF drugs

5.6.3 Ampio Pharmaceuticals Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)

5.7 Kowa Group

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Kowa Group Product Type and Technology

5.7.2.1 Corticosteroids drugs

5.7.2.2 Anti-VEGF drugs

5.7.3 Kowa Group Sales, Revenue, Price of Kowa Group (2015 and 2016)

5.8 Ohr Pharmaceutical

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Ohr Pharmaceutical Product Type and Technology

5.8.2.1 Corticosteroids drugs

5.8.2.2 Anti-VEGF drugs

5.8.3 Ohr Pharmaceutical Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)

5.9 Promedior

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Promedior Product Type and Technology

5.9.2.1 Corticosteroids drugs

5.9.2.2 Anti-VEGF drugs

5.9.3 Promedior Sales, Revenue, Price of Promedior (2015 and 2016)

5.10 PSivida

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 PSivida Product Type and Technology

5.10.2.1 Corticosteroids drugs

5.10.2.2 Anti-VEGF drugs

5.10.3 PSivida Sales, Revenue, Price of PSivida (2015 and 2016)

5.11 Quark Pharmaceuticals

5.12 ThromboGenics

6 Diabetic Retinopathy Technology and Development Trend

6.1 Diabetic Retinopathy Technology Analysis

6.2 Diabetic Retinopathy Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Diabetic Retinopathy

Table Classification of Diabetic Retinopathy

Figure USA Sales Market Share of Diabetic Retinopathy by Types in 2015

Figure Corticosteroids drugs Picture

Figure Anti-VEGF drugs Picture

Figure Others Picture

Table Applications of Diabetic Retinopathy

Figure USA Sales Market Share of Diabetic Retinopathy by Applications in 2015

Table USA Diabetic Retinopathy Sales, Revenue and Price (2011-2021)

Figure USA Diabetic Retinopathy Sales and Growth Rate (2011-2021)

Figure USA Diabetic Retinopathy Revenue and Growth Rate (2011-2021)

Table USA AAA Sales of Key Manufacturers (2015 and 2016)

Table USA AAA Sales Share by Manufacturers (2015 and 2016)

Figure 2015 AAA Sales Share by Manufacturers

Figure 2016 AAA Sales Share by Manufacturers

Table USA AAA Revenue by Manufacturers (2015 and 2016)

Table USA AAA Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA AAA Revenue Share by Manufacturers

Table 2016 USA AAA Revenue Share by Manufacturers

Table USA AAA Sales and Market Share by Type (2011-2021)

Table USA AAA Sales Share by Type (2011-2021)

Figure Sales Market Share of AAA by Type (2011-2021)

Figure USA AAA Sales Growth Rate by Type (2011-2021)

Table USA AAA Revenue and Market Share by Type (2011-2021)

Table USA AAA Revenue Share by Type (2011-2021)

Figure Revenue Market Share of AAA by Type (2011-2021)

Figure USA AAA Revenue Growth Rate by Type (2011-2021)

Table USA AAA Sales and Market Share by Application (2011-2021)

Table USA AAA Sales Share by Application (2011-2021)

Figure Sales Market Share of AAA by Application (2011-2021)

Figure USA AAA Sales Growth Rate by Application (2011-2021)

Table Bayer Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Bayer (2015 and 2016)

Table F. Hoffmann-La Roche Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)

Table Novartis Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Novartis (2015 and 2016)

Table Regeneron Pharmaceuticals Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Regeneron Pharmaceuticals (2015 and 2016)

Table Alimera Sciences Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Alimera Sciences (2015 and 2016)

Table Ampio Pharmaceuticals Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Ampio Pharmaceuticals (2015 and 2016)

Table Kowa Group Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Kowa Group (2015 and 2016)

Table Ohr Pharmaceutical Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Ohr Pharmaceutical (2015 and 2016)

Table Promedior Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Promedior (2015 and 2016)

Table PSivida Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of PSivida (2015 and 2016)

Table Quark Pharmaceuticals Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of Quark Pharmaceuticals (2015 and 2016)

Table ThromboGenics Basic Information List

Table Diabetic Retinopathy Sales, Revenue, Price of ThromboGenics (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370